Top 25 Companies in Global Adult and Adolescent Vaccines Market (2025–2035): Competitive Analysis & Forecast
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The adult and adolescent vaccines market refers to the global healthcare sector focused on vaccines administered to individuals aged roughly 10 years and above to prevent infectious diseases such as influenza, HPV, hepatitis, pneumococcal disease, and shingles. Market growth is driven by rising infectious disease prevalence, aging populations, increasing awareness of preventive healthcare, and government immunization programs. Technological advancements and expanding vaccination initiatives create significant opportunities. Recent developments include pharmaceutical investments and acquisitions to strengthen adult vaccine portfolios and expand immunization coverage globally.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Adult and Adolescent Vaccines Market.
Adult and Adolescent Vaccines Market Size & Statistics
- The Market Size for Adult and Adolescent Vaccines Was Estimated to be worth USD 24.18 Billion in 2024.
- The Market is Going to Expand at a CAGR of 8.45% between 2025 and 2035.
- The Global Adult and Adolescent Vaccines Market Size is anticipated to reach USD 59.03 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the Adult and Adolescent Vaccines Market
- Asia Pacific is expected to grow the fastest during the forecast period in the Adult and Adolescent Vaccines Market.
Regional growth and demand
Asia Pacific is expected to grow the fastest during the forecast period in the Adult and Adolescent Vaccines market. Asia Pacific is expected to grow fastest due to expanding healthcare infrastructure, large population base, rising immunization awareness, and increasing government vaccination initiatives in emerging economies.
North America is expected to generate the highest demand during the forecast period in the Adult and Adolescent Vaccines market. North America is expected to generate the highest demand due to advanced healthcare systems, strong vaccination programs, high healthcare spending, and continuous vaccine innovation.
Top 10 Trends in the Adult and Adolescent Vaccines Market
- Expansion of Adult Immunization Programs
- Rising Demand for Combination Vaccines
- Increasing Focus on Preventive Healthcare
- Growth in mRNA Vaccine Technology
- Government Funding and Immunization Campaigns
- Development of Next-Generation Vaccines
- Increasing Awareness of HPV and Influenza Vaccination
- Strategic Collaborations Among Pharmaceutical Companies
- Expansion of Vaccine Distribution Infrastructure
- Growth in Emerging Markets
1.Expansion of Adult Immunization Programs
Governments and health organizations worldwide are expanding adult immunization programs to prevent infectious diseases such as influenza, pneumococcal disease, and hepatitis. Increasing public health campaigns, workplace vaccination drives, and improved accessibility to vaccines are encouraging more adults and adolescents to receive routine immunizations, supporting steady growth in vaccine demand.
2. Rising Demand for Combination Vaccines
Combination vaccines that protect against multiple diseases in a single dose are gaining popularity due to convenience and improved compliance. These vaccines reduce the number of injections required, simplify immunization schedules, and enhance coverage among adolescents and adults. Pharmaceutical companies are increasingly investing in research to develop advanced multi-antigen vaccine formulations.
3. Increasing Focus on Preventive Healthcare
Healthcare systems are shifting toward preventive care to reduce the long-term burden of infectious diseases. Vaccination is becoming a key preventive strategy for adults and adolescents, supported by insurance coverage, workplace health programs, and physician recommendations. This growing emphasis on prevention is significantly boosting the adoption of adult vaccines worldwide.
4. Growth in mRNA Vaccine Technology
The success of mRNA vaccines during the COVID-19 pandemic accelerated innovation in vaccine technology. Pharmaceutical companies are now exploring mRNA platforms to develop vaccines for influenza, RSV, and other infectious diseases affecting adults and adolescents. These vaccines offer faster development timelines, high efficacy, and flexibility in responding to emerging pathogens.
5. Government Funding and Immunization Campaigns
Governments across developed and developing countries are increasing funding for vaccination programs to improve public health outcomes. National immunization campaigns, subsidies, and partnerships with healthcare organizations are helping expand vaccine coverage among adults and adolescents. Such initiatives play a critical role in strengthening vaccine accessibility and boosting market growth.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Adult and Adolescent Vaccines Market.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the Adult and Adolescent Vaccines market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 25 Companies Leading the Adult and Adolescent Vaccines Market
- Pfizer Inc.
- GlaxoSmithKline plc
- Sanofi
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson
- Moderna, Inc.
- BioNTech SE
- Novartis AG
- CSL Limited
- Takeda Pharmaceutical Company Limited
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Sinovac Biotech Ltd.
- CureVac N.V.
- Valneva SE
- Dynavax Technologies Corporation
- Inovio Pharmaceuticals, Inc.
- VBI Vaccines Inc.
- Emergent BioSolutions Inc.
- Bavarian Nordic
- Daiichi Sankyo Company Limited
- Panacea Biotec
- Novavax, Inc.
- Abbott Laboratories
- Pfizer Inc.
Headquarters: New York, United States
Pfizer is a global biopharmaceutical leader with a strong presence in adult and adolescent vaccines. The company develops vaccines for pneumococcal disease, COVID-19, and meningococcal infections. Its advanced mRNA technology and extensive research investments strengthen its vaccine portfolio and global immunization programs.
- GlaxoSmithKline plc.
Headquarters: London, United Kingdom
GlaxoSmithKline (GSK) is one of the world’s largest vaccine producers with a broad portfolio including shingles, meningitis, hepatitis, and influenza vaccines. The company focuses on advanced adjuvant systems and recombinant technologies, supporting lifelong immunization strategies and expanding adult vaccination coverage globally.
- Sanofi
Headquarters: Paris, France
Sanofi is a major global healthcare company with a strong vaccine division known as Sanofi Pasteur. It develops vaccines for influenza, meningococcal diseases, and other infectious conditions affecting adults and adolescents. Continuous investments in research, partnerships, and new vaccine platforms strengthen its leadership in immunization markets.
- Merck & Co., Inc.
Headquarters: Rahway, New Jersey, United States
Merck & Co. is a leading pharmaceutical company recognized for vaccines such as HPV and hepatitis immunizations. The company invests heavily in vaccine research and clinical trials to address emerging infectious diseases and improve adult immunization programs worldwide through innovation and global health collaborations.
- Teva Moderna, Inc.
Headquarters: Cambridge, Massachusetts, United States
Moderna is a biotechnology company specializing in mRNA-based vaccines and therapeutics. It gained global recognition through its COVID-19 vaccine and continues to develop vaccines for influenza, RSV, and other infectious diseases targeting adult populations, leveraging its scalable mRNA platform and rapid development capabilities.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Adult and Adolescent Vaccines Market.
Are you ready to discover more about the Adult and Adolescent Vaccines market?
The report provides an in-depth analysis of the leading companies operating in the global Adult and Adolescent Vaccines market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Pfizer Inc.
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- GlaxoSmithKline plc
- Sanofi
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson
- Moderna, Inc.
- BioNTech SE
- Novartis AG
- Others.
Our Top Reports:
https://www.sphericalinsights.com/reports/china-foodservice-market
https://www.sphericalinsights.com/reports/europe-lpg-market
https://www.sphericalinsights.com/reports/united-kingdom-swine-vaccines-market
Conclusion
The adult and adolescent vaccines market is expected to witness significant growth through 2035, driven by rising awareness of preventive healthcare, expanding immunization programs, and advancements in vaccine technologies such as mRNA platforms. Increasing government funding, strong pharmaceutical research investments, and growing vaccination coverage in emerging economies will further support market expansion. Leading pharmaceutical companies continue to innovate and strengthen vaccine portfolios to address infectious diseases affecting adults and adolescents. As healthcare systems emphasize disease prevention and global immunization initiatives, the market is poised for sustained growth and improved public health outcomes worldwide.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Adult and Adolescent Vaccines Market.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?